Bahleda, Rastislav
Le Deley, Marie-Cécile
Bernard, Apexa
Chaturvedi, Shalini
Hanley, Michael
Poterie, Audrey
Gazzah, Anas
Varga, Andreea
Touat, Mehdi
Deutsch, Eric
Massard, Christophe
Van De Velde, Helgi
Hollebecque, Antoine
Sallansonnet-Froment, Magali
Ricard, Damien
Taillia, Hervé
Angevin, Eric
Ribrag, Vincent
Soria, Jean-Charles
Funding for this research was provided by:
Janssen Pharmaceuticals
Article History
Received: 6 February 2017
Accepted: 23 October 2017
First Online: 2 November 2017
Compliance with ethical standards
:
: HVDV: Employment Millennium Pharmaceuticals, Cambridge, MA; stock ownership Johnson&Johnson.AB: Employment Johnson & Johnson, Raritan, NJ; stock ownership Johnson&Johnson.MH: Employment Millennium Pharmaceuticals Inc., Cambridge, MA, USA.The other authors declare that they have no conflict of interests.